Mumps in Children

Introduction to Mumps in Children

Mumps is a highly contagious viral infection primarily affecting the salivary glands. It is caused by the mumps virus, a member of the Paramyxoviridae family. Although vaccination has significantly reduced its incidence in many countries, outbreaks can still occur, particularly in close-contact settings like schools and colleges.

Key points about mumps:

Caused by a single-stranded RNA virus
Primarily affects children, but can occur at any age
Characterized by swelling of the salivary glands (parotitis)
Can lead to various complications, especially in post-pubertal individuals
Preventable through vaccination

Understanding mumps in children is crucial for healthcare providers to ensure proper diagnosis, management, and prevention strategies.

Epidemiology of Mumps in Children

The epidemiology of mumps has changed significantly since the introduction of widespread vaccination programs:

Incidence:
- Pre-vaccine era: Common childhood disease with peak incidence in 5-9 year olds
- Post-vaccine era: Dramatic decrease, but outbreaks still occur
Age Distribution:
- Shift towards older children, adolescents, and young adults in vaccinated populations
- In unvaccinated populations, still primarily affects children 2-12 years old
Seasonality:
- Peak incidence in late winter and spring in temperate climates
- Less pronounced seasonality in tropical regions
Transmission:
- Spread through respiratory droplets or direct contact with saliva
- Highly contagious: Attack rates up to 86% in susceptible household contacts
Risk Factors:
- Unvaccinated or under-vaccinated status
- Crowded living conditions (dormitories, military barracks)
- Travel to areas with high mumps prevalence
- Immunocompromised state
Global Impact:
- Significant reduction in endemic countries with vaccination programs
- Still a major health concern in countries without routine vaccination

Understanding the epidemiological patterns of mumps is crucial for identifying at-risk populations, implementing targeted vaccination strategies, and managing outbreaks effectively.

Pathophysiology of Mumps

The pathophysiology of mumps involves several stages from viral entry to systemic spread:

Viral Entry and Initial Replication:
- The mumps virus enters through the upper respiratory tract or oral mucosa
- Initial replication occurs in epithelial cells of the upper respiratory tract
Viremia and Spread:
- The virus spreads to local lymph nodes
- Primary viremia occurs, allowing systemic spread
- The virus can infect various organs, including salivary glands, testes, pancreas, and central nervous system
Salivary Gland Involvement:
- The parotid glands are the most commonly affected salivary glands
- Viral replication leads to inflammation and swelling of the glands
- Inflammatory response includes infiltration of lymphocytes and macrophages
Immune Response:
- Both humoral and cell-mediated immunity are involved
- IgM antibodies appear early in infection, followed by IgG antibodies
- T-cell responses are crucial for viral clearance
Organ-Specific Effects:
- Orchitis: Inflammation of the testes, more common in post-pubertal males
- Meningitis: Viral invasion of the central nervous system
- Pancreatitis: Inflammation of the pancreas, potentially leading to transient hyperglycemia

The pathophysiology of mumps explains its diverse clinical manifestations and potential complications. Understanding these processes is crucial for managing the disease and its sequelae effectively.

Clinical Presentation of Mumps in Children

The clinical presentation of mumps can vary from asymptomatic infection to severe systemic disease. In children, the classic presentation is parotitis, but other manifestations can occur:

1. Prodromal Phase (1-2 days):

Low-grade fever
Malaise
Anorexia
Headache
Myalgia

2. Parotitis Phase:

Swelling of salivary glands, typically the parotid glands
Usually bilateral, but can be unilateral initially
Pain and tenderness in the affected glands
Difficulty swallowing or chewing
Dry mouth
Swelling may last 7-10 days

3. Other Clinical Features:

Fever (usually 38-40°C or 100.4-104°F)
Ear pain
Sore throat
Fatigue
Abdominal pain (may indicate pancreatitis)

4. Age-Specific Presentations:

Infants and Young Children:
- May present with nonspecific symptoms without apparent parotitis
- Respiratory symptoms may be more prominent
Adolescents:
- Higher risk of orchitis in males
- Increased risk of meningitis and encephalitis

5. Atypical Presentations:

Asymptomatic infection (especially in vaccinated individuals)
Isolated orchitis without parotitis
Meningitis or encephalitis without apparent parotitis

It's important to note that up to 20% of mumps infections may be asymptomatic, especially in vaccinated individuals. The incubation period typically ranges from 16 to 18 days, with a range of 12 to 25 days. Recognizing the diverse clinical presentations of mumps is crucial for timely diagnosis and appropriate management.

Diagnosis of Mumps in Children

Diagnosing mumps involves a combination of clinical assessment and laboratory confirmation. The approach includes:

1. Clinical Diagnosis:

Based on characteristic symptoms, especially parotitis
History of exposure or being in an area with a mumps outbreak
Vaccination status assessment

2. Laboratory Tests:

Viral Detection:
- RT-PCR (Reverse Transcription Polymerase Chain Reaction):
  - Most sensitive and specific test
  - Can detect virus in saliva, urine, or CSF
  - Best performed within the first 3 days of parotitis onset
- Viral Culture:
  - Less commonly used due to longer turnaround time
  - Can be performed on saliva or throat swab
Serological Tests:
- IgM Antibodies:
  - Detectable within a few days of symptom onset
  - May be falsely negative in vaccinated individuals
- IgG Antibodies:
  - Rise in titer or seroconversion between acute and convalescent samples
  - Less useful in vaccinated individuals

3. Specimen Collection:

Buccal or oral swab for viral detection
Blood sample for serological tests
Urine sample can also be used for viral detection

4. Differential Diagnosis:

Consider other causes of parotitis or similar presentations:

Viral infections: EBV, parainfluenza, influenza A
Bacterial parotitis
Salivary gland obstruction
Allergic or drug reactions
Juvenile recurrent parotitis
Rare causes: HIV, tuberculosis, sarcoidosis

5. Additional Tests:

Amylase levels may be elevated due to parotid inflammation
CSF analysis if meningitis is suspected
Testicular ultrasound if orchitis is suspected

Accurate diagnosis is crucial for appropriate patient management and public health measures. In outbreak situations, clinical diagnosis may be sufficient, but laboratory confirmation is recommended, especially in sporadic cases or in vaccinated individuals.

Treatment of Mumps in Children

Treatment for mumps is primarily supportive, as it is a viral infection without specific antiviral therapy. The main goals are to alleviate symptoms and prevent complications. The approach includes:

1. Supportive Care:

Rest and adequate hydration
Pain relief and fever reduction:
- Acetaminophen or ibuprofen
- Avoid aspirin due to risk of Reye's syndrome
Warm or cold compresses to the swollen glands for comfort
Soft, bland diet to minimize chewing discomfort
Avoid acidic foods and beverages that may stimulate saliva production

2. Management of Specific Symptoms:

Parotitis:
- Gentle massage of the gland
- Sialagogues (lemon drops, sour candies) to stimulate saliva flow
Orchitis:
- Scrotal support and ice packs
- Analgesics for pain relief
Meningitis:
- Close monitoring
- Pain management
- Adequate hydration

3. Isolation and Infection Control:

Isolation for 5 days after onset of parotid swelling
Good hand hygiene
Avoid sharing utensils or personal items

4. Monitoring for Complications:

Regular assessment for signs of meningitis, encephalitis, or orchitis
Follow-up for potential long-term complications

5. Nutritional Support:

Ensure adequate fluid intake
Soft, easily swallowed foods if eating is difficult
Consider nutritional supplements if prolonged poor intake

6. Rarely Used Interventions:

Intravenous immunoglobulin: Considered in severe cases or immunocompromised patients, but evidence is limited
Corticosteroids: Not routinely recommended, may be considered in severe orchitis

Most children with mumps recover completely within a few weeks with supportive care. However, close monitoring is essential to identify and manage any complications promptly. Education about the course of the illness and infection control measures is crucial for patients and their families.

Complications of Mumps in Children

While many children recover from mumps without significant issues, complications can occur. The risk and nature of complications can vary with age and gender:

1. Central Nervous System Complications:

Aseptic Meningitis:
- Most common complication, occurring in up to 10% of cases
- Usually mild and self-limiting
Encephalitis:
- Rare but serious complication (less than 1% of cases)
- Can lead to neurological sequelae
Cerebellar Ataxia: Rare complication affecting coordination

2. Reproductive System Complications:

Orchitis (inflammation of testicles):
- Occurs in up to 30% of post-pubertal males
- Usually unilateral, but can be bilateral
- May lead to testicular atrophy in severe cases
- Rare cause of infertility
Oophoritis (inflammation of ovaries):
- Occurs in about 5% of post-pubertal females
- Generally milder than orchitis

3. Other Organ Complications:

Pancreatitis:
- Occurs in about 3-5% of cases
- Usually mild and self-limiting
Thyroiditis: Rare complication
Myocarditis: Rare but potentially serious heart inflammation
Nephritis: Uncommon kidney inflammation
Arthritis: Temporary joint inflammation

4. Sensory Organ Complications:

Hearing Loss:
- Can be transient or permanent
- Occurs in about 1 in 20,000 cases
- More common in adults than children
Optic Neuritis: Rare inflammation of the optic nerve

5. Pregnancy-Related Complications:

Increased risk of spontaneous abortion in first trimester
No clear evidence of congenital malformations

6. Long-Term Sequelae:

Most complications resolve without long-term effects
Rare cases of permanent hearing loss or neurological deficits
Potential for decreased fertility in males with severe bilateral orchitis

Risk Factors for Complications:

Age: Some complications (e.g., orchitis) more common in post-pubertal individuals
Gender: Orchitis in males, oophoritis in females
Immune status: Immunocompromised individuals at higher risk
Vaccination status: Unvaccinated individuals at higher risk for complications

While complications can occur, it's important to note that most children recover from mumps without significant long-term effects. Early recognition and appropriate management of complications are crucial for optimal outcomes. Regular monitoring during the course of the illness is essential to identify any developing complications promptly.

Prevention of Mumps in Children

Prevention of mumps primarily relies on vaccination and public health measures. The strategies include:

1. Vaccination:

MMR (Measles, Mumps, Rubella) Vaccine:
- Recommended schedule: First dose at 12-15 months, second dose at 4-6 years
- Efficacy: Two doses are about 88% effective in preventing mumps
- Can be given as MMRV (includes varicella) in some countries
Catch-up Vaccination:
- For unvaccinated older children and adolescents
- Particularly important before entering high-risk settings (e.g., college)
Outbreak Control:
- Additional dose may be recommended during outbreaks

2. Infection Control Measures:

Isolation of infected individuals:
- Stay home for at least 5 days after symptom onset
- Avoid close contact with others, especially in school or work settings
Good hygiene practices:
- Regular handwashing
- Covering mouth and nose when coughing or sneezing
- Avoiding sharing utensils or drinks

3. Public Health Strategies:

Surveillance and reporting of mumps cases
Contact tracing during outbreaks
Education and awareness programs
School and community-based vaccination programs

4. Travel Recommendations:

Ensure up-to-date vaccination before traveling to high-risk areas
Be aware of potential exposure during international travel

5. Special Considerations:

Healthcare workers: Ensure immunity through vaccination or documented prior infection
Immunocompromised individuals: May require special vaccination considerations
Pregnant women: Avoid MMR vaccine during pregnancy

6. Long-term Prevention Strategies:

Maintaining high vaccination coverage in the population
Ongoing research into vaccine efficacy and potential need for additional doses
Monitoring for potential virus mutations that could affect vaccine effectiveness

Prevention of mumps is crucial not only for individual health but also for public health. While vaccination has dramatically reduced the incidence of mumps, ongoing vigilance and adherence to preventive measures remain important, especially in the face of occasional outbreaks.

6. Mumps in Children

What is the causative agent of mumps?
Mumps virus (Paramyxovirus family)
What is the primary mode of transmission for mumps?
Respiratory droplets and direct contact with saliva
What is the incubation period for mumps?
16-18 days (range 12-25 days)
What is the most characteristic symptom of mumps?
Parotid gland swelling (parotitis)
What percentage of mumps infections are asymptomatic?
Approximately 20-30%
How long does parotid swelling typically last in mumps?
7-10 days
What is the most common complication of mumps in post-pubertal males?
Orchitis (testicular inflammation)
What percentage of post-pubertal males with mumps develop orchitis?
15-30%
Can mumps cause infertility in males?
Rarely, severe bilateral orchitis can lead to infertility
What is the most serious neurological complication of mumps?
Aseptic meningitis
What percentage of mumps cases develop aseptic meningitis?
Up to 10%
Can mumps cause encephalitis?
Yes, but it's rare (less than 1% of cases)
What is the risk of mumps infection during pregnancy?
Increased risk of miscarriage in the first trimester
How is mumps typically diagnosed?
Clinical symptoms and RT-PCR or serological testing
What vaccine is used to prevent mumps?
MMR (Measles, Mumps, Rubella) vaccine
At what age is the first dose of MMR vaccine typically given?
12-15 months
When is the second dose of MMR vaccine usually administered?
4-6 years of age
What is the efficacy of two doses of mumps vaccine?
88% (range: 79-95%)
Can mumps outbreaks occur in vaccinated populations?
Yes, especially in close-contact settings like schools or colleges
How long is a person with mumps considered infectious?
From 2 days before to 5 days after parotid swelling onset
What type of genetic material does the mumps virus contain?
Single-stranded negative-sense RNA
What is the approximate size of a mumps virus particle?
150-200 nanometers
Which cells does the mumps virus primarily infect?
Epithelial cells of the salivary glands and other glandular tissues
Can mumps cause pancreatitis in children?
Yes, but it's uncommon (about 4% of cases)
What is the recommended treatment for uncomplicated mumps?
Symptomatic treatment (rest, hydration, pain relief)
Can a person get mumps more than once?
Rarely, second infections have been reported but are uncommon
What is the global annual incidence of mumps in regions with high vaccine coverage?
Less than 1 case per 100,000 population
How does the mumps virus affect the inner ear?
It can cause sensorineural hearing loss (usually unilateral and permanent)
What is the name of the mumps protein responsible for fusion with host cells?
F protein (fusion protein)
Can mumps be eliminated through vaccination programs?
Difficult to eliminate completely due to its high infectivity and vaccine efficacy

External Resources